Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-08-20

Clinical Trial Update: Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS) [NA]

View source ↗

Summary

A clinical trial update describes a conditioning protocol for autologous bone marrow transplantation in multiple sclerosis, evaluating safety and efficacy, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Multiple Sclerosis | NA | Status: UNKNOWN